Kramer et al. then examined GAB2 mRNA levels in primary human AML samples from The Cancer Genome Atlas (TCGA) database and found that GAB2 expression was higher in PML::RARA-positive tumor samples than in normal CD34+ cells (22). The gene discussed is CD34; the disease is acute myeloid leukemia.